Mode of Action Frameworks: A Critical Analysis

REFERENCES

• Andersen , M. E. and Dennison , J. E. 2001 . Mode of action and tissue dosimetry in current and future risk assessments . Sci. Total Environ. , 274 : 3 – 14 .
   PubMed Web of Science ®Google Scholar
• Barton , H. A. , Cogliano , V. J. , Flowers , L. , Valcovic , L. , Setzer , R. W. and Woodruff , T. J. 2005 . Assessing susceptibility from early-life exposure to carcinogens . Environ. Health Perspect. , 113 : 1125 – 1133 .
   PubMed Web of Science ®Google Scholar
• Becking , G. C. 1995 . Use of mechanistic information in risk assessment for toxic chemicals . Toxicol. Lett. , 77 : 15 – 24 .
   PubMed Web of Science ®Google Scholar
• Bogdanffy , M. S. , Daston , G. , Faustman , E. M. , Kimmel , C. A. , Kimmel , G. L. , Seed , J. and Vu , V. 2001 . Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop . Toxicol. Sci. , 61 : 18 – 31 .
   PubMed Web of Science ®Google Scholar
• Boobis , A. R. , Cohen , S. M. , Dellarco , V. , McGregor , D. , Meek , M. E. , Vickers , C. , Willcocks , D. and Farland , W. 2006 . IPCS framework for analyzing the relevance of a cancer mode of action for humans . Crit. Rev. Toxicol. , 36 : 781 – 792 .
   PubMed Web of Science ®Google Scholar
• Borgert , C. J. , Quill , T. F. , McCarty , L. S. and Mason , A. M. 2004 . Can mode of action predict mixture toxicity for risk assessment? . Toxicol. Appl. Pharmacol. , 201 : 85 – 96 .
   PubMed Web of Science ®Google Scholar
• Carpy , S. A. , Kobel , W. and Doe , J. 2000 . Health risk of low-dose pesticides mixtures: A review of the 1985–1998 literature on combination toxicology and health risk assessment . J. Toxicol. Environ. Health B , 3 : 1 – 25 .
   PubMed Web of Science ®Google Scholar
• Cassee , F. R. , Groten , J. P. , van Bladeren , P. J. and Feron , V. J. 1998 . Toxicological evaluation and risk assessment of chemical mixtures . Crit. Rev.Toxicol. , 28 : 73 – 101 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. 2005 . Use of mode of action in risk assessment: Past, present, and future . Regul. Toxicol. Pharmacol. , 42 : 3 – 14 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. and Andersen , M. E. 2004 . Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: An example with trichloroethylene . Crit. Rev. Toxicol. , 34 : 385 – 445 .
   PubMed Web of Science ®Google Scholar
• Cohen , S. M. , Klaunig , J. , Meek , M. E. , Hill , R. N. , Pastoor , T. , Lehman-McKeeman , L. , Bucher , J. , Longfellow , D. G. , Seed , J. , Dellarco , V. , Fenner-Crisp , P. and Patton , D. 2004 . Evaluating the human relevance of chemically induced animal tumors . Toxicol. Sci. , 78 : 181 – 186 .
   PubMed Web of Science ®Google Scholar
• Conolly , R. B. 1995 . Cancer and non-cancer risk assessment: Not so different if you consider mechanisms . Toxicology , 102 : 179 – 188 .
   PubMed Web of Science ®Google Scholar
• Crofton , K. M. and Zoeller , R. T. 2005 . Mode of action: Neurotoxicity induced by thyroid hormone disruption during development—Hearing loss resulting from exposure to PHAHs . Crit. Rev. Toxicol. , 35 : 757 – 769 .
   PubMed Web of Science ®Google Scholar
• Daston , G. P. 1997 . Advances in understanding mechanisms of toxicity and implications for risk assessment . Reprod. Toxicol. , 11 : 389 – 396 .
   PubMed Web of Science ®Google Scholar
• Dellarco , V. L. and Baetcke , K. 2005 . A risk assessment perspective: application of mode of action and human relevance frameworks to the analysis of rodent tumor data . Toxicol. Sci. , 86 : 1 – 3 .
   PubMed Web of Science ®Google Scholar
• Euling , S. Y. and Kimmel , C. A. 2001 . Developmental stage sensitivity and mode of action information for androgen agonists and antagonists . Sci. Total Environ. , 274 : 103 – 113 .
   PubMed Web of Science ®Google Scholar
• Farland, W. 2006. Memorandum: Implementation of the cancer guidelines and accompanying supplemental guidance—Science Policy Council Cancer Guidelines Implementation Workgroup Communication II: Performing risk assessments that include carcinogens described in the Supplemental Guidance as having a mutagenic mode of action.. http://epa.gov/osa/spc/pdfs/CGIWGCommunication_II.pdf" (Accessed: 0 July 2007 ).
   Google Scholar
• Faustman , E. M. , Ponce , R. A. , Seeley , M. R. and Whittaker , S. G. 1997 . “ Experimental approach to evaluate mechanisms of developmental toxicity ” . In Handbook of developmental toxicology , Edited by: Hood , R. D. 13 – 41 . New York : CRC Press .
   Google Scholar
• Foster , P. M. 2005 . Mode of action: Impaired fetal Leydig cell function—Effects on male reproductive development produced by certain phthalate esters . Crit. Rev. Toxicol. , 35 : 713 – 719 .
   PubMed Web of Science ®Google Scholar
• Ginsberg , G. L. 2003 . Assessing cancer risks from short-term exposures in children . Risk Anal. , 23 : 19 – 34 .
   PubMed Web of Science ®Google Scholar
• Gohlke , J. M. , Griffith , W. C. and Faustman , E. M. 2005 . A systems-based computational model for dose-response comparisons of two mode of action hypotheses for ethanol-induced neurodevelopmental toxicity . Toxicol. Sci. , 86 : 470 – 484 .
   PubMed Web of Science ®Google Scholar
• Goodman , J. I. 1994 . A rational approach to risk assessment requires the use of biological information: An analysis of the National Toxicology Program (NTP), final report of the advisory review by the NTP Board of Scientific Counselors . Regul. Toxicol. Pharmacol. , 19 : 51 – 59 .
   PubMed Web of Science ®Google Scholar
• Goodman , J. I. 1998 . The traditional toxicologic paradigm is correct: Dose influences mechanism . Environ. Health Perspect. , 106 ( Suppl. 1 ) : 285 – 288 .
   PubMedGoogle Scholar
• Goodman , J. I. 2001 . A perspective on current and future uses of alternative models for carcinogenicity testing . Toxicol. Pathol. , 29 ( Suppl. ) : 173 – 176 .
   PubMed Web of Science ®Google Scholar
• Gray , G. M. , Baskin , S. I. , Charnley , G. , Cohen , J. T. , Gold , L. S. , Kerkvliet , N. I. , Koenig , H. M. , Lewis , S. C. , McClain , R. M. , Rhomberg , L. R. , Snyder , J. W. and Weekley , L. B. 2001 . The Annapolis accords on the use of toxicology in risk assessment and decision-making: An Annapolis center workshop report . Toxicol. Methods , 11 : 225 – 231 .
   Google Scholar
• Guzelian , P. S. , Victoroff , M. S. , Halmes , N. C. , James , R. C. and Guzelian , C. P. 2005 . Evidence-based toxicology: A comprehensive framework for causation . Hum. Exp. Toxicol. , 24 : 161 – 201 .
   PubMed Web of Science ®Google Scholar
• Haber , L. T. , Maier , Zhao A., Q. , Dollarhide , J. S. , Savage , R. E. and Dourson , M. L. 2001 . Applications of mechanistic data in risk assessment: the past, present, and future . Toxicol. Sci. , 61 : 32 – 39 .
   PubMed Web of Science ®Google Scholar
• Hill , A. B. 1965 . The environment and disease: Association or causation? . Proc. R. Soc. Med. , 58 : 295 – 300 .
   PubMed Web of Science ®Google Scholar
• Hofler , M. 2005 . Causal inference based on counterfactuals . BMC Med. Res. Methodol. , 5 : 28
   PubMedGoogle Scholar
• Hofler , M. 2006 . Getting causal considerations back on the right track . Emerg. Themes Epidemiol. , 3 : 8
   PubMedGoogle Scholar
• Holsapple , M. P. , Pitot , H. C. , Cohen , S. M. , Boobis , A. R. , Klaunig , J. E. , Pastoor , T. , Dellarco , V. L. and Dragan , Y. P. 2006 . Mode of action in relevance of rodent liver tumors to human cancer risk . Toxicol. Sci. , 89 : 51 – 56 .
   PubMed Web of Science ®Google Scholar
• Holson , J. F. , Stump , D. G. , Pearce , L. B. , Watson , R. E. and DeSesso , J. M. 2005 . Mode of action: Yolk sac poisoning and impeded histiotrophic nutrition—HBOC-related congenital malformations . Crit. Rev. Toxicol. , 35 : 739 – 745 .
   PubMed Web of Science ®Google Scholar
• Hoyer , P. B. 2001 . Reproductive toxicology: Current and future directions . Biochem. Pharmacol. , 62 : 1557 – 1564 .
   PubMed Web of Science ®Google Scholar
• International Programme on Chemical Safety . 1997 . IPCS workshop on chemical-specific risk assessment for carcinogens—Chemical selection, March 3–5, 1997
   Google Scholar
• International Programme on Chemical Safety. 1998. IPCS workshop on issues in cancer risk assessment. http://www.who.int/ipcs/publications/methods/harmonization/en/issues_cancer.pdf (Accessed: 6 July 2007 ).
   Google Scholar
• International Programme on Chemical Safety. 1999. IPCS harmonization workshop—Conceptual framework for cancer risk assessment. http://www.who.int/ipcs/publications/methods/harmonization/en/framework_cancer_ra.pdf (Accessed: 6 July 2007 ).
   Google Scholar
• International Programme on Chemical Safety. 2005. IPCS framework for analysing the relevance of a cancer mode of action for humans. http://www.who.int/ipcs/methods/harmonization/areas/frameworktextreview.pdf (Accessed: 6 July 2007 ).
   Google Scholar
• Kavlock , R. and Cummings , A. 2005 . Mode of action: Inhibition of androgen receptor function—Vinclozolin-induced malformations in reproductive development . Crit. Rev. Toxicol. , 35 : 721 – 726 .
   PubMed Web of Science ®Google Scholar
• Kavlock , R. and Cummings , A. 2005 . Mode of action: reduction of testosterone availability—Molinate-induced inhibition of spermatogenesis . Crit. Rev. Toxicol. , 35 : 685 – 690 .
   PubMed Web of Science ®Google Scholar
• Lutz , W. K. 1998 . Dose-response relationships in chemical carcinogenesis: Superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes . Mutat. Res. , 405 ( 2 ) : 117 – 124 .
   PubMed Web of Science ®Google Scholar
• Meek , M. E. , Bucher , J. R. , Cohen , S. M. , Dellarco , V. , Hill , R. N. , Lehman-McKeeman , L. D. , Longfellow , D. G. , Pastoor , T. , Seed , J. and Patton , D. E. 2003 . A framework for human relevance analysis of information on carcinogenic modes of action . Crit. Rev. Toxicol. , 33 : 591 – 653 .
   PubMed Web of Science ®Google Scholar
• National Research Council . 1994 . Science and judgement in risk assessment , Washington, DC : Taylor & Francis .
   Google Scholar
• Page , N. P. , Singh , D. V. , Farland , W. , Goodman , J. I. , Conolly , R. B. , Andersen , M. E. , Clewell , H. J. , Frederick , C. B. , Yamasaki , H. and Lucier , G. 1997 . Implementation of EPA revised cancer assessment guidelines: Incorporation of mechanistic and pharmacokinetic data . Fundam. Appl. Toxicol. , 37 : 16 – 36 .
   PubMedGoogle Scholar
• Pastoor , T. , Rose , P. , Lloyd , S. , Peffer , R. and Green , T. 2005 . Case study: Weight of evidence evaluation of the human health relevance of thiamethoxam-related mouse liver tumors . Toxicol. Sci. , 86 : 56 – 60 .
   PubMed Web of Science ®Google Scholar
• Preston , R. J. and Williams , G. M. 2005 . DNA-reactive carcinogens: mode of action and human cancer hazard . Crit. Rev. Toxicol. , 35 : 673 – 683 .
   PubMed Web of Science ®Google Scholar
• Rothman , K. J. and Greenland , S. 2005 . Causation and causal inference in epidemiology . Am. J. Public Health , 95 ( Suppl. 1 ) : S144 – S150 .
   PubMed Web of Science ®Google Scholar
• Schlosser , P. M. and Bogdanffy , M. S. 1999 . Determining modes of action for biologically based risk assessments . Regul. Toxicol. Pharmacol. , 30 : 75 – 79 .
   PubMed Web of Science ®Google Scholar
• Schoeny , R. , Haber , L. and Dourson , M. 2006 . Data considerations for regulation of water contaminants . Toxicology , 221 : 217 – 224 .
   PubMed Web of Science ®Google Scholar
• Seed , J. , Carney , E. W. , Corley , R. A. , Crofton , K. M. , DeSesso , J. M. , Foster , P. M. , Kavlock , R. , Kimmel , G. , Klaunig , J. , Meek , M. E. , Preston , R. J. , Slikker , W. Jr. , Tabacova , S. , Williams , G. M. , Wiltse , J. , Zoeller , R. T. , Fenner-Crisp , P. and Patton , D. E. 2005 . Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data . Crit. Rev. Toxicol. , 35 : 664 – 672 .
   PubMed Web of Science ®Google Scholar
• Slikker , W. Jr. , Xu , Z. A. , Levin , E. D. and Slotkin , T. A. 2005 . Mode of action: Disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction—Developmental neurotoxicity of nicotine . Crit. Rev. Toxicol. , 35 : 703 – 711 .
   PubMed Web of Science ®Google Scholar
• Sonich-Mullin , C. , Fielder , R. , Wiltse , J. , Baetcke , K. , Dempsey , J. , Fenner-Crisp , P. , Grant , D. , Hartley , M. , Knaap , A. , Kroese , D. , Mangelsdorf , I. , Meek , E. , Rice , J. M. and Younes , M. 2001 . IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis . Regul. Toxicol. Pharmacol. , 34 : 146 – 152 .
   PubMed Web of Science ®Google Scholar
• Tabacova , S. 2005 . Mode of action: angiotensin-converting enzyme inhibition—Developmental effects associated with exposure to ACE inhibitors . Crit. Rev. Toxicol. , 35 : 747 – 755 .
   PubMed Web of Science ®Google Scholar
• Thygesen , L. C. , Andersen , G. S. and Andersen , H. 2005 . A philosophical analysis of the Hill criteria . J. Epidemiol. Commun. Health , 59 : 512 – 526 .
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency. 1986. Guidelines for carcinogen risk assessment. http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=54933 (Accessed: 6 July 2007 ).
   Google Scholar
• U.S. Environmental Protection Agency. 2002. Determination of the appropriate FQPA safety factor(s) in tolerance assessment. http://www.epa.gov/oppfead1/cb/csb_page/updates/10xrevised.htm (Accessed: 6 July 2007 ).
   Google Scholar
• U.S. Environmental Protection Agency. 2002. Framework for cumulative risk assessment. http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=54944 (Accessed: 6 July 2007 ).
   Google Scholar
• U.S. Environmental Protection Agency. 2002. Guidance on cumulative risk assessment of pesticide chemicals that have a common mechanism of toxicity. http://www.epa.gov/scipoly/sap/meetings/2003/december11/cumulativeguidance2002.pdf (Accessed: 6 July 2007 ).
   Google Scholar
• U.S. Environmental Protection Agency . 2005 . Guidelines for carcinogen risk assessment and supplemental guidance for assessing susceptibility from early-life exposure to carcinogens . Fed. Reg. , 70 ( 66 ) : 17765 – 17817 .
   Google Scholar
• U.S. Environmental Protection Agency. 2006. A framework for assessing health risks of environmental exposures to children. http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=158363 (Accessed: 6 July 2007 ).
   Google Scholar
• Vineis , P. and Kriebel , D. . 2006 . Causal models in epidemiology: Past inheritance and genetic future . Environ. Health , 5 : 21 – 31 .
   PubMedGoogle Scholar
• Weed , D. L. 2002 . Environmental epidemiology: Basics and proof of cause-effect . Toxicology , 18 : 181 – 182 . 399 – 403 .
   Google Scholar
• Weed , D. L. 2005 . Weight of evidence: A review of concept and methods . Risk Anal. , 25 : 1545 – 1557 .
   PubMed Web of Science ®Google Scholar
• Wiltse , J. 2005 . Mode of action: Inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin—Developmental effects of valproic acid . Crit. Rev. Toxicol. , 35 : 727 – 738 .
   PubMed Web of Science ®Google Scholar